India, Sept. 24 -- This company belongs to India and is a pharma company with a product line that contains therapeutic segments like gynaecology, orthopaedics, dermatology, and childcare. This company operates its business in the form of branded pharmaceuticals and has expanded its product line through organic and inorganic means.

The shares of Jagsonpal Pharma are currently trading at Rs. 241 . 16, by 6.88%. The company has a market capitalization of Rs. 1,588.06 crore. The stock's 52 week high is Rs. 264.50 and its 52 week low is Rs. 155.00. In the past 6 months the stock has delivered a return of 32.73%.

What's The News? Jagsonpal Pharmaceuticals entered into the BTA with Group Pharmaceuticals on 23rd September, 2026, wherein it is ...